Mersana (MRSN) PT Raised to $18 at Wedbush, Following Clinical Business Update
Tweet Send to a Friend
Wedbush analyst David Nierengarten raised the price target on Mersana (NASDAQ: MRSN) to $18.00 (from $17.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
